natgillin/translations-raw huggingface dataset:
DMF penetrated through the clothes onto consumers’ skin [2] where it caused painful skin contact dermatitis, including itching, irritation, redness, and burns; in some cases, acute respiratory troubles were reported.
DMF je prodrl skozi oblačila do kože potrošnikov [2], na kateri je povzročil boleč kožni kontaktni dermatitis, vključno s srbečico, razdraženostjo, rdečico in opeklinami, v nekaterih primerih so poročali tudi o hudih težavah z dihanjem.
The dermatitis was particularly difficult to treat.
Dermatitis je bilo še posebej težko zdraviti.
The presence of DMF is thus a serious risk.
Zato prisotnost DMF predstavlja resno tveganje za potrošnika.
Under Article 13 of Directive 2001/95/EC, if the European Commission becomes aware that certain products present a serious risk to the health and safety of consumers, it may, subject to certain conditions, adopt a decision requiring Member States to take measures intended in particular to restrict or make subject to specific conditions the availability on the market of such products.
V skladu s členom 13 Direktive 2001/95/ES lahko Evropska komisija, če pri nekaterih proizvodih ugotovi resno ogrožanje zdravja in varnosti potrošnikov, pod določenimi pogoji izda odločbo, s katero od držav članic zahteva, da sprejmejo ukrepe, s katerimi zlasti omejijo dostopnost takih proizvodov na trgu ali zanje določijo posebne pogoje.
Such a decision may be adopted if (a) Member States differ significantly on the approach adopted or to be adopted to deal with the risk concerned; (b) the risk cannot, in view of the nature of the safety issue, be dealt with in a manner compatible with the degree of urgency of the case under other procedures laid down by the specific Community legislation applicable to the product concerned; and (c) the risk can be eliminated effectively only by adopting appropriate measures applicable at Community level, in order to ensure a consistent and high level of protection of the health and safety of consumers and the proper functioning of the internal market.
Takšna odločba se lahko izda, če (a) se države članice pomembno razlikujejo v sprejetem ali nameravanem pristopu k obravnavanju nevarnosti, (b) z drugimi postopki, opredeljenimi v posebni zakonodaji Skupnosti, ki se nanaša na take proizvode, glede na naravo vprašanja varnosti proizvoda nevarnosti ni mogoče odvrniti tako, da bi bilo primerno stopnji nujnosti primera, ter (c) se lahko nevarnost učinkovito odpravi le s primernimi ukrepi, sprejetimi na ravni Skupnosti, da se zagotovi dosledna in visoka raven varovanja zdravja in varnosti potrošnikov ter ustrezno delovanje notranjega trga.
A clinical study on humans [3] (patch tests) with leather furniture and patches of pure DMF showed strong reactions in the most severe case down to 1 mg/kg.
Klinična študija na ljudeh [3] (testi z obliži) z usnjenim pohištvom in obliži s čistim DMF je pokazala močne reakcije, v najhujšem primeru tudi na samo 1 mg/kg snovi.
On the basis of this study, France adopted a decree [4] which bans the importation and placing on the market of seating and footwear containing DMF.
Na podlagi te študije je Francija sprejela uredbo [4], ki prepoveduje uvoz in dajanje na trg sedežev in obutve, ki vsebujejo DMF.
The French decree also requires the recall of all seating and footwear which visibly contains, or the packaging of which visibly contains, DMF.
Francoska uredba prav tako zahteva odpoklic vseh sedežev in obutve, ki vidno vsebujejo DMF ali pa ga vidno vsebuje njihova embalaža.
The duration of the decree is limited to 1 year.
Trajanje uredbe je omejeno na eno leto.
Belgium issued a decree [5], on the basis of the same study, which bans the placing on the market of all articles and products containing DMF.
Belgija je na podlagi iste študije izdala uredbo [5], ki prepoveduje dajanje na trg vseh izdelkov in proizvodov, ki vsebujejo DMF.
Spain issued measures [6] banning DMF in all consumer products coming into contact with the skin.
Španija je sprejela ukrepe [6], ki prepovedujejo DMF v vseh proizvodih, namenjenih potrošnikom, ki pridejo v stik s kožo.
Belgium, Spain and France are the only Member States having adopted specific regulatory measures to address the serious risk to consumer health from the biocide DMF.
Belgija, Španija in Francija so edine države članice, ki so sprejele posebne zakonodajne ukrepe za odpravo resne nevarnosti za zdravje potrošnikov zaradi biocida DMF.
Under Article 2(1)(a) of Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (the Biocides Directive) [7], biocidal products are defined as active substances and preparations containing one or more active substances, which are intended to destroy, deter, render harmless, prevent the action of, or otherwise exert a controlling effect on any harmful organism by chemical or biological means.
V členu 2(1)(a) Direktive 98/8/ES Evropskega parlamenta in Sveta z dne 16. februarja 1998 o dajanju biocidnih pripravkov v promet („direktiva o biocidih“) [7] so biocidni pripravki aktivne snovi in pripravki, ki vsebujejo eno ali več aktivnih snovi, predvideni, da se z njimi uničuje, odvrača, naredi neškodljivo, prepreči delovanje ali kako drugače vpliva na škodljivi organizem na kemični ali biološki način.
Article 3(1) of the Biocides Directive requires Member States to prescribe that a biocidal product shall not be placed on the market and used in their territory unless it has been authorised in accordance with the Directive; and Article 5(1)(b)(iii) of the Directive provides that Member States shall authorise a biocidal product only if, amongst other things, it has no unacceptable effects itself or as a result of its residues, on human health, directly or indirectly.
Člen 3(1) direktive o biocidih od držav članic zahteva, da predpišejo, da se biocidni pripravek ne daje v promet in se na njenem ozemlju ne uporablja, če zanj ni bilo izdano dovoljenje v skladu z Direktivo, in člen 5(1)(b)(iii) Direktive določa, da države članice izdajo dovoljenje za biocidni pripravek samo, če med drugim nima nobenih nesprejemljivih učinkov sam po sebi ali njegovi ostanki na zdravje človeka, neposredno ali posredno.
Thus, very high safety standards have to be fulfilled before a biocidal product can be authorised.
Preden biocidni pripravek dobi dovoljenje, morajo tako biti izpolnjeni zelo visoki varnostni standardi.
Biocidal products containing DMF are not authorised in the Community in accordance with the Biocides Directive.
Biocidni pripravki, ki vsebujejo DMF, v skladu z direktivo o biocidih v Skupnosti nimajo dovoljenja.
Thus, biocidal products containing DMF are not legally available in the Community for the treatment of products against moulds, and thus no product manufactured in the EU can legally contain DMF.
Biocidni pripravki, ki vsebujejo DMF v Skupnosti niso zakonito dostopni za obdelavo proizvodov proti plesni in tako noben proizvod, proizveden v EU, ne more zakonito vsebovati DMF.
However, there is no restriction when DMF is present in products (or raw materials of products) that are imported into the Community.
Toda ni omejitev, če je DMF že prisoten v proizvodih (ali surovinah proizvodov), ki se uvozijo v Skupnost.
Any restriction of DMF to be put in place under Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC [8] would be impossible in the short term and would thus not suffice with regard to the urgency of the present risk management need.
Kakršne koli omejitve, ki jih je treba uvesti v skladu z Uredbo (ES) št. 1907/2006 Evropskega Parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH), o ustanovitvi Evropske agencije za kemikalije ter spremembi Direktive 1999/45/ES ter razveljavitvi Uredbe Sveta (EGS) št. 793/93 in Uredbe Komisije (ES) št. 1488/94 ter Direktive Sveta 76/769/EGS in direktiv Komisije 91/155/EGS, 93/67/EGS, 93/105/ES in 2000/21/ES [8], bi bile nemogoče v kratkem času in tako ne bi zadostovale glede na nujnost trenutne potrebe po obvladovanju tveganja.
In these circumstances, Member States should be required to ensure that no products containing DMF are placed or made available on the market, in order to prevent the serious risk posed by these products to consumers, until a permanent solution becomes available.
V takšnih okoliščinah morajo države članice zagotoviti, da noben proizvod, ki vsebuje DMF, ni dan na trg ali na njem ni dostopen, da bi se preprečila resna nevarnost, ki ga ti proizvodi pomenijo za potrošnike, dokler ne bo na razpolago trajna rešitev.
The presence of DMF in products should be determined against the maximum limit of 0,1 mg DMF per kg of product or part of the product.
Prisotnost DMF v proizvodih je treba določiti glede na najvišjo zgornjo mejo 0,1 mg DMF na kg proizvoda ali njegovega dela.
This is considered to be sufficiently below the concentration of 1 mg/kg which showed a strong reaction in the patch tests mentioned above.
Ocenjuje se, da je ta dovolj pod koncentracijo 1 mg/kg, ki je pokazala močno reakcijo v zgoraj navedenih testih z obliži.
The maximum limit of 0,1 mg/kg thus appropriately addresses the serious risk from DMF in products.
Najvišja zgornja meja 0,1 mg/kg je tako ustrezna za odpravljanje resne nevarnosti zaradi DMF v proizvodih.
Accordingly, the analytical method employed should be able to reliably quantify 0,1 mg DMF per kg of product or part of the product.
V skladu s tem bi moralo biti z uporabljeno analitsko metodo mogoče zanesljivo določiti mero 0,1 mg DMF na kg proizvoda ali njegovega dela.
This means that the method’s quantification limit should be 0,1 mg/kg or less.
To pomeni, da mora biti zgornja meja, določena po tej metodi, 0,1 mg/kg ali manj.
Member States must carry out market surveillance and enforcement activities to prevent risks posed by unsafe products to the health and safety of consumers.
Države članice morajo izvajati nadzor trga in ukrepe izvrševanja zakonodaje za preprečitev nevarnosti, ki jih za zdravje in varnost potrošnikov predstavljajo nevarni proizvodi.
A short transition period is necessary in the interests of both the Member States, who must ensure that this Decision will be applied, and producers and distributors who are subject to the obligation to make available on the market only safe products.
Kratko prehodno obdobje je potrebno zaradi koristi vseh držav članic, ki morajo zagotoviti, da se bo ta odločba uporabljala, ter proizvajalcev in distributerjev, od katerih se zahteva, da omogočajo dostop na trg samo varnim proizvodom.
The shortest possible transition period is appropriate, consistent with the need to prevent further incidents of serious damage to the health and safety of consumers and to ensure proportionality.
Primerno je najkrajše možno prehodno obdobje, ki bo usklajeno z nujnostjo preprečevanja nadaljnjih primerov resnega ogrožanja zdravja in varnosti potrošnikov in bo zagotovilo sorazmernost.
The measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 15 of Directive 2001/95/EC,
Ukrepi, predvideni s to odločbo, so v skladu z mnenjem Odbora, ustanovljenega s členom 15 Direktive 2001/95/ES –
‘DMF’ means the chemical dimethylfumarate, with the IUPAC name Dimethyl (E)-butenedioate, the CAS No 624-49-7 and the Einecs No 210-849-0;
„DMF“ pomeni kemikalijo dimetil fumarat, z imenom po IUPAC dimetil (E)-butendioat, s številko CAS 624-49-7 in s številko s seznama EINECS 210-849-0;
‘product’ means any product as defined in Article 2(a) of Directive 2001/95/EC;
„proizvod“ pomeni vsak proizvod, kot je opredeljen v členu 2(a) Direktive 2001/95/ES;
‘product containing DMF’ means any product or any part of a product where either:
„proizvod, ki vsebuje DMF“ pomeni vsak proizvod ali njegov del, pri katerem:
the presence of DMF is declared, such as on one or more pouches; or
je prisotnost DMF deklarirana, na primer na eni ali več vrečkah, ali
the concentration of DMF is greater than 0,1 mg/kg of the weight of the product or part of the product;
je koncentracija DMF večja od 0,1 mg/kg na težo proizvoda ali njegovega dela;
‘placing on the market’ means the first making available of a product on the Community market;
„dajanje na trg“ pomeni, da je proizvod prvič dostopen na trgu Skupnosti;
‘made available on the market’ means supplied for distribution, consumption or use on the Community market in the course of a commercial activity, whether in return for payment or free of charge.
„dostopnost na trgu“ pomeni dobavo za distribucijo, porabo ali uporabo na trgu Skupnosti v okviru gospodarske dejavnosti, bodisi odplačno ali neodplačno.
As of 1 May 2009 Member States shall ensure that products containing DMF are prohibited from being placed or made available on the market.
Od 1. maja 2009 države članice zagotovijo, da je za proizvode, ki vsebujejo DMF, prepovedano dajanje na trg ali njihova dostopnost na trgu.
As of 1 May 2009 Member States shall ensure that products containing DMF and already placed or made available on the market are withdrawn from the market and recalled from consumers, and that consumers are adequately informed of the risk posed by such products.
Od 1. maja 2009 države članice zagotovijo, da se proizvodi, ki vsebujejo DMF in so že dani na trg ali so na njem dostopni, umaknejo s trga in odpokličejo od potrošnikov, ter da so potrošniki ustrezno obveščeni o tveganju, ki ga takšni proizvodi predstavljajo.
Member States shall take the necessary measures to comply with this Decision, publish those measures and inform the Commission thereof accordingly.
Države članice sprejmejo potrebne ukrepe za uskladitev s to odločbo, jih objavijo in o tem ustrezno obvestijo Komisijo.
This Decision shall be applicable until 15 March 2010.
Odločba se uporablja do 15. marca 2010.
Rantanen T. (2008), ‘The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate, a novel potent contact sensitizer.’
Rantanen T (2008) The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate, a novel potent contact sensitizer. Concise communication.
Concise communication, British Journal of Dermatology 159: p. 218-221.
British Journal of Dermatology 159: 218–221.
Ministry for the Economy, Industry and Employment, Decree of 4 December 2008 suspending the placing on the market of seats and footwear containing DMF from the market.
Ministrstvo za gospodarstvo, industrijo in zaposlovanje, Uredba z dne 4. decembra 2008 o ustavitvi dajanja na trg sedežev in obutve, ki vsebuje DMF.
JORF (French Official Journal), 10 December 2008, Text 17 of 108.
JORF (Francoski Uradni list), 10. december 2008, besedilo 17 od 108.
The Minister for Public Health and the Minister for Consumer Protection, Ministerial Decree concerning the prohibition of placing articles and products containing DMF on the market.
Minister za javno zdravje in minister za varstvo potrošnikov, Ministrska uredba o prepovedi dajanja na trg izdelkov in proizvodov, ki vsebujejo DMF.
Belgisch Staatsblad/Moniteur belge (Belgian Official Journal), 12 January 2009.
Belgisch Staatsblad/Moniteur belge (Belgijski Uradni list), 12. januar 2009.
Resolution of 22 December 2008 of the National Consumer Institute BOE (Spanish Official Journal) No 18, 21 January 2009, Sec.
Resolucija z dne 22. decembra 2008 Nacionalnega inštituta za potrošnike. BOE (Španski Uradni list) št. 18, 21. januar 2009, sec.
V-B, p. 5474.
V-B, str. 5474.
OJ L 396, 30.12.2006, p. 1, as corrected by OJ L 136, 29.5.2007, p. 3.
UL L 396, 30.12.2006, str.1, popravljena različica v UL L 136, 29.5.2007, str. 3.
Williams J.D.L., et al.
Williams JDL, et al (2008) An outbreak of furniture dermatitis in the U.K.
(2008), ‘An outbreak of furniture dermatitis in the UK’, British Journal of Dermatology 159: p. 233-234.
British Journal of Dermatology 159: 233–234.
concerning derogations from certain provisions of Regulation (EC) No 177/2008 of the European Parliament and of the Council establishing a common framework for business registers for statistical purposes
v zvezi z odstopanji od nekaterih določb Uredbe (ES) št. 177/2008 Evropskega parlamenta in Sveta o vzpostavitvi skupnega okvira za poslovne registre v statistične namene
(notified under document number C(2009) 1568)
(notificirano pod dokumentarno številko C(2009) 1568)
(Only the Danish, Dutch, English, Estonian, French, German, Greek, Latvian, Lithuanian, Maltese, Polish and Slovak texts are authentic)
(Besedila v danskem, nizozemskem, angleškem, estonskem, francoskem, nemškem, grškem, latvijskem, litovskem, malteškem, poljskem in slovaškem jeziku so edina verodostojna)
Having regard to Regulation (EC) No 177/2008 of the European Parliament and of the Council of 20 February 2008 establishing a common framework for business registers for statistical purposes and repealing Council Regulation (EEC) No 2186/93 [1], and in particular Article 14 thereof,
ob upoštevanju Uredbe (ES) št. 177/2008 [1] Evropskega parlamenta in Sveta z dne 20. februarja 2008 o vzpostavitvi skupnega okvira za poslovne registre v statistične namene in o razveljavitvi Uredbe Sveta (EGS) št. 2186/93 ter zlasti člena 14 Uredbe,
Having regard to the requests made by the Kingdom of Belgium, the Kingdom of Denmark, the Federal Republic of Germany, the Republic of Estonia, Ireland, the Hellenic Republic, the French Republic, the Republic of Latvia, the Republic of Lithuania, the Grand Duchy of Luxembourg, the Republic of Malta, the Kingdom of the Netherlands, the Republic of Austria, the Republic of Poland and the Slovak Republic,
ob upoštevanju zahtevkov Kraljevine Belgije, Kraljevine Danske, Zvezne republike Nemčije, Republike Estonije, Irske, Helenske republike, Francoske republike, Republike Latvije, Republike Litve, Velikega vojvodstva Luksemburg, Republike Malte, Kraljevine Nizozemske, Republike Avstrije, Republike Poljske in Slovaške republike,
Regulation (EC) No 177/2008 established a new common framework for business registers exclusively for statistical purposes in order to maintain the development of business registers in a harmonised framework.
Uredba (ES) št. 177/2008 je vzpostavila nov skupni okvir za poslovne registre izključno za statistične namene za vzdrževanje razvoja poslovnih registrov v usklajenem okviru.
Some Member States have requested such derogations to be granted.
Nekatere države članice so zaprosile za odobritev takšnih odstopanj.
It seems justified to grant those derogations, as the Member States’ requests are based on a legitimate need to further adapt their national statistical systems,
Odobritev navedenih odstopanj se zdi utemeljena, saj zahtevki držav članic temeljijo na upravičeni potrebi po nadaljnjem prilagajanju njihovih nacionalnih statističnih sistemov –
Derogations are hereby granted to the Member States listed in the Annex, under the conditions and subject to the limits set out therein, in order to enable those Member States to bring their respective national statistical systems into conformity with Regulation (EC) No 177/2008.
Državam članicam, ki so navedene v Prilogi, se odobrijo odstopanja v skladu s pogoji in omejitvami iz Priloge, da se zagotovi uskladitev njihovih nacionalnih statističnih sistemov z Uredbo (ES) št. 177/2008.
This decision is addressed to the Kingdom of Belgium, the Kingdom of Denmark, the Federal Republic of Germany, the Republic of Estonia, Ireland, the Hellenic Republic, the French Republic, the Republic of Latvia, the Republic of Lithuania, the Grand Duchy of Luxembourg, the Republic of Malta, the Kingdom of the Netherlands, the Republic of Austria, the Republic of Poland and the Slovak Republic.
Ta odločba je naslovljena na Kraljevino Belgijo, Kraljevino Dansko, Zvezno republiko Nemčijo, Republiko Estonijo, Irsko, Helensko republiko, Francosko republiko, Republiko Latvijo, Republiko Litvo, Veliko vojvodstvo Luksemburg, Republiko Malto, Kraljevino Nizozemsko, Republiko Avstrijo, Republiko Poljsko in Slovaško republiko.
Granted derogation
Odobreno odstopanje
Characteristics 4.1, 4.2a, 4.3 to 4.7 and 4.9
značilnosti 4.1, 4.2a, 4.3 do 4.7 in 4.9
Characteristics 1.8 to 1.12a, 1.13a, 3.12, 4.11, 4.12a and 4.13a
značilnosti 1.8 do 1.12a, 1.13a, 3.12, 4.11, 4.12a in 4.13a
30 June 2011
junija 2011
Coverage of enterprise groups
zajetje skupin podjetij
30 June 2009
junija 2009
Coverage of enterprise groups not belonging to the largest MNEs transmitted by Eurostat
zajetje skupin podjetij, ki ne pripadajo največjim večnacionalnim podjetjem, seznam katerih pošlje Eurostat
Characteristic 3.11 and latter part of characteristic 1.7a (Reference to customs files or to the register of extra-Community operators)
značilnost 3.11 in zadnji del značilnosti 1.7a (sklicevanje na carinski register ali register gospodarskih subjektov zunaj skupnosti)
Agriculture, forestry and fishing, public administration and defence, and compulsory social security
kmetijstvo, gozdarstvo in ribolov, javna uprava in obramba ter obvezna socialna varnost
Characteristic 1.12a
značilnost 1.12a
Full derogation
polno odstopanje
Characteristic 1.3
značilnost 1.3
Characteristic 3.11
značilnost 3.11;
Characteristics 1.8 to 1.12b, 1.13a, 3.12, 4.1, 4.2a, 4.5 to 4.7, 4.9, 4.13a
značilnosti 1.8 do 1.12b, 1.13a, 3.12, 4.1, 4.2a, 4.5 do 4.7, 4.9, 4.13a
Enterprise groups and their characteristics
skupine podjetij in njihove značilnosti
Agriculture, forestry and fishing, public administration and defence, and compulsory social security, and the additional characteristics relating to enterprise groups
kmetijstvo, gozdarstvo in ribolov, javna uprava in obramba, obvezna socialna varnost ter dodatne značilnosti, povezane s skupinami podjetij
Agriculture, forestry and fishing
kmetijstvo, gozdarstvo in ribolov
30 June 2012
junija 2012
Multinational enterprise groups and their characteristics
skupine večnacionalnih podjetij in njihove značilnosti
The additional characteristics relating to enterprise groups
dodatne značilnosti, povezane s skupinami podjetij
Characteristics 1.12a, 1.13a, 3.11, 4.4, 4.11, 4.12a and 4.13a
značilnosti 1.12a, 1.13a, 3.11, 4.4, 4.11, 4.12a in 4.13a
Characteristic 3.11 concerning sub-sectors (public, national private, foreign controlled) of S.11, S.122, S.123, S.124 and S.125
značilnost 3.11 za podsektorje (javni, nacionalni zasebni, pod tujim nadzorom) s.11, s.122, s.123, s.124 in s.125;
Local units and their characteristics in public administration and defence and in compulsory social security
lokalne enote in njihove značilnosti v javni upravi in obrambi ter v obvezni socialni varnosti
Data on multinational enterprise groups and their transmission to Eurostat
dodatki o skupinah večnacionalnih podjetij in njihovo pošiljanje Eurostatu
Additional characteristics relating to enterprise groups
dodatne značilnosti, povezane s skupinami podjetij
Article 14 of Regulation (EC) No 177/2008 provides that when business registers require a major overhaul, the Commission may grant a derogation at the request of a Member State for a transitional period that shall not exceed 25 March 2010.
Člen 14 Uredbe (ES) št. 177/2008 določa, da lahko Komisija ob potrebi po večji prilagoditvi poslovnih registrov na zahtevo države članice za prehodno obdobje odobri odstopanje, ki traja najpozneje do 25. marca 2010.
For agriculture, forestry and fishing, public administration and defence, and compulsory social security, and for the additional characteristics relating to enterprise groups, the Commission may grant a derogation at the request of a Member State for a transitional period that shall not exceed 25 March 2013.
Za kmetijstvo, gozdarstvo in ribolov, javno upravo in obrambo ter obvezno socialno varnost in za dodatne značilnosti, povezane s skupinami podjetij, lahko Komisija na zahtevo države članice odobri odstopanje za prehodno obdobje, ki traja najpozneje do 25. marca 2013.
(notified under document number C(2009) 1945)
(notificirano pod dokumentarno številko C(2009) 1945)